Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

Abstract Background Lumbrokinase has been widely used for patients with acute ischemic stroke (AIS) in China; however, because rigorously designed studies are lacking, safety and efficacy of lumbrokinase in the treatment of acute ischemic stroke remains largely unknown. In this multicenter, randomiz...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Ying Chen, Yan Liu, Jingjing Zhang, Kehua Zhou, Xuecheng Zhang, Hengheng Dai, Baolin Yang, Hongcai Shang
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMC 2022-04-01
Seri Bilgileri:Trials
Konular:
Lumbrokinase
Aspirin
Acute ischemic stroke
Multicenter randomized controlled trial
Trial protocol
Online Erişim:https://doi.org/10.1186/s13063-022-06200-4

Internet

https://doi.org/10.1186/s13063-022-06200-4

Benzer Materyaller